Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Tax Provisions (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Tax Provisions data on record, last reported at $18000.0 in Q4 2025.

  • For Q4 2025, Tax Provisions rose 63.64% year-over-year to $18000.0; the TTM value through Oct 2025 reached -$75000.0, down 97.37%, while the annual FY2025 figure was -$75000.0, 134.38% down from the prior year.
  • Tax Provisions reached $18000.0 in Q4 2025 per CSBR's latest filing, up from $14000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $32000.0 in Q2 2021 and bottomed at -$130000.0 in Q2 2025.
  • Average Tax Provisions over 5 years is $3800.0, with a median of $14000.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: soared 1100.0% in 2023, then tumbled 505.0% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $12000.0 in 2021, then grew by 16.67% to $14000.0 in 2022, then dropped by 21.43% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then surged by 63.64% to $18000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $18000.0 in Q4 2025, $14000.0 in Q3 2025, and -$130000.0 in Q2 2025.